{"nct_id":"NCT05980598","title":"TransCon (TC) TLR7/8 Agonist, TC IL-2 β/γ, Pembrolizumab Prior to Surgery for Advanced Head and Neck Squamous Cell Carcinoma","status":"TERMINATED","status_verified_date":"2025-07","start_date":"2023-09-29","start_date_type":"ACTUAL","primary_completion_date":"2025-03-28","primary_completion_date_type":"ACTUAL","completion_date":"2025-03-28","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["ASND"]}